Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 02/28/29
Due: 02/28/30
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 08/07/24
Due: 08/07/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) | NCT04783181 | Adrenas Therapeutics Inc | user2@example.com | None | 2021-07-01 | 2029-02-28 | 2030-02-28 | - | - | 2025-07-14 |
| A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181]) | NCT05101902 | Adrenas Therapeutics Inc | user2@example.com | None | 2021-07-01 | 2024-08-07 | 2025-08-07 | - | - | 2025-07-14 |